Linlin Qin
Research Subjects
Linlin Qin has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Stephen G. DiMagno
College of Pharmacy, University of Illinois-Chicago, Chicago, Illinois; and
5 shared publications Bijia Wang
Department of Chemistry and Nebraska Center for Materials and Nanoscience, University of Nebraska, Lincoln, Nebraska 68588-0304, United States
3 shared publicationsKiel D. Neumann
Department of Chemistry University of Nebraska–Lincoln Lincoln NE USA
3 shared publicationsJianyu Liu
Haisco Pharmaceuticals Group Co. Ltd. , 136 Baili Road, Wenjiang District, Chengdu, 611130, China
2 shared publicationsJoseph W. Graskemper
Department of Chemistry and Nebraska Center for Materials and Nanoscience, University of Nebraska, Lincoln, Nebraska 68588-0304, USA
2 shared publicationsXinfeng Luo
Haisco Pharmaceuticals Group Co. Ltd. , 136 Baili Road, Wenjiang District, Chengdu, 611130, China
2 shared publications
Latest Publications
- 12 October 2017
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 60 (20) , 8580-8590
Oral Delivery of Propofol with Methoxymethylphosphonic Acid as the Delivery Vehicle
Phosphonamidate 3a of methoxymethylphosphonic acid (MMPA) with propofol (1) and l-alanine ethyl ester was found to be an efficient scaffold for the oral delivery of compound 1. The synthesis and evaluation of MMPA based phosphonamidates of compound 1, HSK3486 (2), and other phenolic drugs revealed the general application of MMPA as the effective delivery vehicle for phenolic drugs. On the basis of plasma concentrations of compound 1 and SN38 (14), the oral bioavailability of compound 3a and 15 in beagle dogs was found to be 97.6% and 34.1%, respectively.
- 12 October 2017
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 60 (20) , 8580-8590
Oral Delivery of Propofol with Methoxymethylphosphonic Acid as the Delivery Vehicle
Phosphonamidate 3a of methoxymethylphosphonic acid (MMPA) with propofol (1) and l-alanine ethyl ester was found to be an efficient scaffold for the oral delivery of compound 1. The synthesis and evaluation of MMPA based phosphonamidates of compound 1, HSK3486 (2), and other phenolic drugs revealed the general application of MMPA as the effective delivery vehicle for phenolic drugs. On the basis of plasma concentrations of compound 1 and SN38 (14), the oral bioavailability of compound 3a and 15 in beagle dogs was found to be 97.6% and 34.1%, respectively.
- 28 April 2017
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 60 (9) , 3606-3617
Design, Synthesis, and Evaluation of Novel 2,6-Disubstituted Phenol Derivatives as General Anesthetics
A novel series of optically active 2,6-disubstituted alkylphenols with improved anesthetic profiles compared to widely used propofol were synthesized. The incorporation of the cyclopropyl group not only increased the steric effect but also introduced stereoselective effects over their anesthetic properties. Compounds 1, 2, and 6 were selected as potential candidates for further preclinical development including studies of their water-soluble prodrugs. Clinical studies of candidate compound 6 (Haisco HSK3486) as a general anesthetic are being performed in Australia and China.
- 28 April 2017
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 60 (9) , 3606-3617
Design, Synthesis, and Evaluation of Novel 2,6-Disubstituted Phenol Derivatives as General Anesthetics
A novel series of optically active 2,6-disubstituted alkylphenols with improved anesthetic profiles compared to widely used propofol were synthesized. The incorporation of the cyclopropyl group not only increased the steric effect but also introduced stereoselective effects over their anesthetic properties. Compounds 1, 2, and 6 were selected as potential candidates for further preclinical development including studies of their water-soluble prodrugs. Clinical studies of candidate compound 6 (Haisco HSK3486) as a general anesthetic are being performed in Australia and China.
- 21 January 2016
- Published by Wiley in ChemInform
- Vol. 47 (6)
ChemInform Abstract: A Mild and General One-Pot Synthesis of Densely Functionalized Diaryliodonium Salts.
A scalable synthesis is presented which gives access to a wide range of very densely functionalized diaryliodonium salts from aryl iodides under mild conditions.
- 21 January 2016
- Published by Wiley in ChemInform
- Vol. 47 (6)
ChemInform Abstract: A Mild and General One-Pot Synthesis of Densely Functionalized Diaryliodonium Salts.
A scalable synthesis is presented which gives access to a wide range of very densely functionalized diaryliodonium salts from aryl iodides under mild conditions.
- 23 December 2015
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 59 (1) , 30-34
Efficient automated syntheses of high specific activity 6‐[18F]fluorodopamine using a diaryliodonium salt precursor
6‐[18F]Fluorodopamine (6‐[18F]F‐DA) is a positron emission tomography radiopharmaceutical used to image sympathetic cardiac innervation and neuroendocrine tumors. Imaging with 6‐[18F]F‐DA is constrained, in part, by the bioactivity and neurotoxicity of 6‐[19F]fluorodopamine. Furthermore, routine access to this radiotracer is limited by the inherent difficulty of incorporation of [18F]fluoride into electron‐rich aromatic substrates. We describe the simple and direct preparation of high specific activity (SA) 6‐[18F]F‐DA from no‐carrier‐added (n.c.a.) [18F]fluoride. Incorporation of n.c.a. [18F]fluoride into a diaryliodonium salt precursor was achieved in 50–75% radiochemical yields (decay corrected to end of bombardment). Synthesis of 6‐[18F]F‐DA on the IBA Synthera® and GE TRACERlab FX‐FN automated platforms gave 6‐[18F]F‐DA in >99% chemical and radiochemical purities after HPLC purification. The final non‐corrected yields of 6‐[18F]F‐DA were 25 ± 4% (n = 4, 65 min) and 31 ± 6% (n = 3, 75 min) using the Synthera and TRACERlab modules, respectively. Efficient access to high SA 6‐[18F]F‐DA from a diaryliodonium salt precursor and n.c.a. [18F]fluoride is provided by a relatively subtle change in reaction conditions – replacement of a polar aprotic solvent (acetonitrile) with a relatively nonpolar solvent (toluene) during the critical radiofluorination reaction. Implementation of this process on common radiochemistry platforms should make 6‐[18F]F‐DA readily available to the wider imaging community.
- 23 December 2015
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 59 (1) , 30-34
Efficient automated syntheses of high specific activity 6‐[18F]fluorodopamine using a diaryliodonium salt precursor
6‐[18F]Fluorodopamine (6‐[18F]F‐DA) is a positron emission tomography radiopharmaceutical used to image sympathetic cardiac innervation and neuroendocrine tumors. Imaging with 6‐[18F]F‐DA is constrained, in part, by the bioactivity and neurotoxicity of 6‐[19F]fluorodopamine. Furthermore, routine access to this radiotracer is limited by the inherent difficulty of incorporation of [18F]fluoride into electron‐rich aromatic substrates. We describe the simple and direct preparation of high specific activity (SA) 6‐[18F]F‐DA from no‐carrier‐added (n.c.a.) [18F]fluoride. Incorporation of n.c.a. [18F]fluoride into a diaryliodonium salt precursor was achieved in 50–75% radiochemical yields (decay corrected to end of bombardment). Synthesis of 6‐[18F]F‐DA on the IBA Synthera® and GE TRACERlab FX‐FN automated platforms gave 6‐[18F]F‐DA in >99% chemical and radiochemical purities after HPLC purification. The final non‐corrected yields of 6‐[18F]F‐DA were 25 ± 4% (n = 4, 65 min) and 31 ± 6% (n = 3, 75 min) using the Synthera and TRACERlab modules, respectively. Efficient access to high SA 6‐[18F]F‐DA from a diaryliodonium salt precursor and n.c.a. [18F]fluoride is provided by a relatively subtle change in reaction conditions – replacement of a polar aprotic solvent (acetonitrile) with a relatively nonpolar solvent (toluene) during the critical radiofluorination reaction. Implementation of this process on common radiochemistry platforms should make 6‐[18F]F‐DA readily available to the wider imaging community.
- 1 June 2015
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 99 (6) , 2188-2190
A Novel Technique of Long-Segment Tracheal Repair With Extended Bronchial Flap of Right Upper and Main Bronchus Plus Tracheoplasty
- 1 June 2015
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 99 (6) , 2188-2190
A Novel Technique of Long-Segment Tracheal Repair With Extended Bronchial Flap of Right Upper and Main Bronchus Plus Tracheoplasty
- 17 May 2011
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 13 (12) , 3158-3161
Unprecedented Directing Group Ability of Cyclophanes in Arene Fluorinations with Diaryliodonium Salts
For the first time it is shown that exceptionally electron-rich arene rings can be fluorinated exclusively during the reductive elimination reactions of diaryliodonium fluorides. The 5-methoxy[2.2]paracyclophan-4-yl directing group simultaneously reduces unproductive aryne chemistry and eliminates ligand exchange reactions by a combination of steric and electronic effects. Use of the cyclophane directing group permits an unprecedented degree of control in fluorination reactions of diaryliodonium salts.
- 17 May 2011
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 13 (12) , 3158-3161
Unprecedented Directing Group Ability of Cyclophanes in Arene Fluorinations with Diaryliodonium Salts
For the first time it is shown that exceptionally electron-rich arene rings can be fluorinated exclusively during the reductive elimination reactions of diaryliodonium fluorides. The 5-methoxy[2.2]paracyclophan-4-yl directing group simultaneously reduces unproductive aryne chemistry and eliminates ligand exchange reactions by a combination of steric and electronic effects. Use of the cyclophane directing group permits an unprecedented degree of control in fluorination reactions of diaryliodonium salts.
- 9 July 2010
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 12 (15) , 3352-3355
Improved Arene Fluorination Methodology for I(III) Salts
The use of low polarity aromatic solvents (benzene or toluene) and/or the removal of inorganic salts results in dramatically improved yields of fluorinated arenes from diaryliodonium salts. This methodology is shown to “scale down” to the conditions used typically for radiotracer synthesis.
- 9 July 2010
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 12 (15) , 3352-3355
Improved Arene Fluorination Methodology for I(III) Salts
The use of low polarity aromatic solvents (benzene or toluene) and/or the removal of inorganic salts results in dramatically improved yields of fluorinated arenes from diaryliodonium salts. This methodology is shown to “scale down” to the conditions used typically for radiotracer synthesis.
- 26 May 2010
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 49 (24) , 4079-4083
Regiospecific Reductive Elimination from Diaryliodonium Salts
Out‐of‐plane steric bulk furnished by a cyclophane substituent on iodine(III) strongly destabilizes the transition state in the reductive elimination from diaryliodonium salts and leads to regiochemical control (dubbed SECURE), as is demonstrated by computational and experimental studies. This approach should be general for high‐valent main‐group and transition metal ions. X=N3, OAc, PhO, CF3CH2O, SCN, PhS.
- 26 May 2010
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 49 (24) , 4079-4083
Regiospecific Reductive Elimination from Diaryliodonium Salts
Out‐of‐plane steric bulk furnished by a cyclophane substituent on iodine(III) strongly destabilizes the transition state in the reductive elimination from diaryliodonium salts and leads to regiochemical control (dubbed SECURE), as is demonstrated by computational and experimental studies. This approach should be general for high‐valent main‐group and transition metal ions. X=N3, OAc, PhO, CF3CH2O, SCN, PhS.